Skip to main content
Quest Diagnostics

Development & Optimization of a Large Urine Antipsychotic Drug Panel & Observations of Clozapine Internal Standard Enhancement

Society for Forensic Toxicologists
SOFT2022

Cleveland, OH, October 30 - Nov 4, 2022

Oral presentation: Development & Optimization of a Large Urine Antipsychotic Drug Panel & Observations of Clozapine Internal Standard Enhancement

Authors: Meli TM, Dui W, Thomassian KO, Dermartirosian A, Vandell VE, Smith MP, Edinboro LE, Bartock SH

Specialties: Prescription Drug Monitoring, Toxicology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.